BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Collateral Therapeutics is defunct.

Fate: Acquired by Schering, March 2002, $140M stock


------------------
If you believe any of this information is incorrect, please let us know.